Celltrion Holdings IPO

The Pinkfong Company Inc., the creator of the billion-view video Baby Shark, has launched the process of an initial public offering on South Korea&r...

The National Pension Service (NPS) plans to raise its equity allocation to about 55% of its assets by 2030 from 40.4% as of the end of February, Sou...

Tencent Music Entertainment Group is set to become the second-largest shareholder of SM Entertainment Co. by acquiring HYBE Co.'s remaining shares i...

Celltrion Inc., South Korea’s largest biosimilar developer, will issue bonus shares to bolster its stock performance, which has been in the do...

South Korea’s largest institutional investor, the National Pension Service (NPS), remains a strong backer of the country’s top four fina...

Global private equity firm KKR & Co. Inc., formerly known as Kohlberg Kravis Roberts & Co., has sold a 9.5% stake in HD Hyundai Marine Solut...

Samsung Group is stepping up efforts to venture into the space infrastructure industry, a sector analysts say remains a blue ocean where South Korea...

Centroid Investment Partners, a South Korean private equity firm, has confirmed plans to divest its controlling stake in US sports equipment manufac...

POSCO Future M Co., South Korea’s leading battery materials maker, is set to raise 1.1 trillion won ($771 million) through a rights offering a...

Lotte Group, South Korea’s fifth-largest conglomerate by assets, will buy back a stake in Lotte Global Logistics Co. from the latter’s f...

South Korean low-cost carriers (LCCs), including Air Premia Inc. and Air Busan Co., have been expanding into underserved smaller cities, but also dr...

Hankook & Company Co., the holding company of Hankook Tire & Technology Co., announced Thursday a plan to launch a wholly owned corporate ve...

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

South Korea’s top four financial holding companies – Shinhan, KB, Hana and Woori – reported stellar earnings for the first quarter...

LG Electronics Inc. is mulling putting off an initial public offering of its wholly owned subsidiary in India amid growing volatility in the global ...

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Hylium Industries Inc., South Korea’s hydrogen liquefier manufacturer, has signed a deal to supply high-capacity liquefied hydrogen storage ta...

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Kakao Corp., South Korea’s largest mobile platform, is looking to sell a majority stake in Kakao Entertainment Corp., dropping a plan to take ...

Kakao Entertainment Corp. has been divesting unprofitable music labels and digital content platforms, which it has gobbled up over the past few year...

LG Electronics Inc. is set to list its wholly owned subsidiary in India on the country's stock exchange in early May, aiming to raise up to $1.5 bil...

South Korea’s Constitutional Court permanently removed President Yoon Suk Yeol from office on Friday, making him the country’s second pr...

South Korea’s Constitutional Court on Friday will give its ruling on President Yoon Suk Yeol, who was impeached in December for declaring mart...

South Korea’s chemical-to-defense conglomerate Hanwha Group Chairman Kim Seung-youn will hand over half of his holdings in the conglomerate&rs...

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, has agreed to buy a stake in Australian asset mana...

South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...

Hanwha Energy Corp., wholly owned by Hanwha Group Chairman Kim Seung-youn’s three sons, has embarked on the process of going public – a ...

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...